Greenlight Biosciences Inc., a biotechnology company developing RNA-based solutions for agriculture and pharmaceutical applications, has received regulatory approval to begin the first phase 1/2 clinical trial of its COVID-19 vaccine candidate in Rwanda.
Read More
One big topic from Google searchers is noticeably absent this year: Covid-19. Last year, vaccination and preventing infection were of great interest, but this year saw no mention of coronavirus in the top health and wellness searches.
Read More
A Duke University scientist said he’s learned the reason for the loss of smell during long COVID.
Read More
Long COVID leaves some people with long-term symptoms, but it can be deadly, too. It played a part in at least 3,544 deaths in the United States in the first 30 months of the Covid-19 pandemic, a new report says.
Read More
An advance in the fight against COVID-19 could be in the making. New research of an experimental COVID-19 vaccine in an infant model was led by researchers from the UNC School of Medicine, Weill Cornell Medicine and University of California, Davis.
Read More
Employees at the world’s biggest Apple iPhone factory were beaten and detained in protests over pay amid anti-virus controls, according to witnesses and videos on social media Wednesday, as tensions mount over Chinese efforts to combat a renewed rise in infections.
Read More
Albert Bourla, CEO of drugmaker Pfizer, has tested positive for Covid-19 and has “very mild symptoms,” he said in a tweet on Monday.
Read More
A U.S. Food and Drug Administration decision to grant broader emergency use authorization to Qorvo Biotechnologies’ COVID diagnostic test is significantly expanding the product’s reach.
Read More
The Duke Clinical Research Institute (DCRI) has been named the Clinical Trials Data Coordinating Center for large-scale national research studies aimed at understanding and improving the treatment of long COVID.
Read More
